A woman who died of ovarian cancer claimed the powder contributed to her disease
More suits are expected; J&J is expected to appeal
A jury in St. Louis has awarded $72 million in damages on a woman’s
claim that her longtime use of baby powder and other Johnson & Johnson
products contributed to the ovarian cancer that killed her.
The St. Louis Circuit Court jury found that the company failed to warn
the public and conspired to hide the truth, said Jim Onder, one of the
Johnson & Johnson, a health care giant based in New Brunswick, N.J.,
is expected to appeal. It issued a statement Tuesday insisting the products are safe.
The plaintiffs’ lawyers said it was the first jury in the nation
to award damages over claims that are the basis of at least 1,200 suits
in St. Louis and elsewhere.
The verdict in favor of Jacqueline Fox was for $10 million in actual damages
and $62 million in punitive damages. About half the punitive damages would
go toward the Missouri Crime Victim Compensation Fund, Onder said.
Fox, 62, of Birmingham, Ala., died last fall, about 2 1/2 years after being
diagnosed. Her son, Marvin Salter of Jacksonville, Fla., became plaintiff
after her death. Jurors heard from Fox in an audio deposition.
The suit claimed her use for more than 35 years of talc-containing products,
such as Johnson’s Baby Powder and Shower to Shower body powder for
feminine hygiene, contributed to her cancer.
The more than three-week trial culminated in nearly five hours of deliberations
Monday that delivered a decision Monday night. Jere Beasley, one of Fox’s
lawyers, said the vote was 10-2.
One juror, Jerome Kendrick, 50, said he and nine women voted in favor of
Fox, two men against.
The company’s internal memos “pretty much sealed my opinion,”
Kendrick said. “They tried to cover up and influence the boards
that regulate cosmetics.” He added, “They could have at least
put a warning label on the box but they didn’t. They did nothing.”
He said the $62 million total was calculated at $1 million for each year
of Fox’s life.
Salter, a 46-year-old mortgage banker, said, “I was speechless when
we heard the initial number.” He added, “To think how groundbreaking
this could be for so many other women.”
He said Johnson & Johnson is a household name he always trusted. “My
reaction was disbelief. How can a company have known about this relationship
between talc and ovarian cancer since the 1970s and not disclosed it?”
He was the only biological child of Fox, a single mother who also raised
Onder said that after being diagnosed with Stage 3 ovarian cancer, Fox
contacted lawyers based on a TV ad about talc. “The sad part is,
she had to learn about it from lawyer ads, while Johnson & Johnson
tried to hide the truth from her,” he said.
Beasley said the jury found against Johnson & Johnson, a holding company,
and Johnson & Johnson Consumer Companies, Inc., but did not fault
another defendant, the talc producer, Imerys Talc America, Inc.
Carol Goodrich, a spokeswoman for Johnson & Johnson, said in an email
Tuesday, “We have no higher responsibility than the health and safety
of consumers, and we are disappointed with the outcome of the trial.”
She added, “We sympathize with the plaintiff’s family but
firmly believe the safety of cosmetic talc is supported by decades of
Onder said, “All their internal documents show that they knew talc
caused ovarian cancer, and actively undertook to hide the truth, not only
from the governmental regulators but from the public.” He said the
company spent 30 years preparing for litigation over it.
He said one company internal document talks about declining product use
because of increased awareness of the health risk, and how to grow the
franchise by targeting blacks and Hispanics as the highest users of talcum
powder. Fox was black.
Beasley said, “We were able to prove that approximately 1,500 die
each year because of the talc involvement.”
He said his Alabama firm heard from more than 6,000 potential clients.
The case ended up in St. Louis after he and a Mississippi lawyer joined
with Onder here to represent several clients. Fox’s case was the
first to go to trial. Others will be in state court in April and in federal
court in July.
Onder said overall there are about 1,000 plaintiffs in St. Louis and 200
in New Jersey state court.
Onder said Fox’s claim was part of a “mass tort case”
that joins plaintiffs together to share expenses but handles trials individually
since, unlike in a class action case, the plaintiffs don’t all claim
identical damages. “Some people were cured, some weren’t,”
Talcum powder is made from talc, a mineral. Fox’s lawyers said corn
starch is a safer alternative but the company chose not to use it.
The American Cancer Society’s website says “it has been suggested
that talcum powder might cause cancer in the ovaries if the powder particles
(applied to the genital area or on sanitary napkins, diaphragms, or condoms)
were to travel through the vagina, uterus, and fallopian tubes to the
But the society says studies have mixed results, some showing a slightly
increased risk and some showing none. The research continues. An estimated
22,280 U.S. women will be diagnosed with ovarian cancer this year, and
about 14,240 women will die of it.
An epidemiologist who testified for Fox estimated about 10 percent of those
who die have ovarian cancers linked to talc.
A pathologist found talc in Fox’s ovaries, which caused the inflammation
which in turn caused her cancer, Beasley said.
Salter said his mother, who died Oct. 6, did not sue for the money. “It
was a fight,” he said, “so others are warned.”